XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements
 12 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

The Company previously accounted for its outstanding Private Warrants as components of equity instead of as derivative liabilities. The warrant agreement governing the Private Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant.

 

On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). The SEC Statement advises, among other things, that certain adjustments generally present in SPAC warrants preclude such warrants from being accounted for as equity, which terms are similar to those contained in the warrant agreement

 

In further consideration of the SEC Statement, the Company’s management further evaluated the Private Warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Private Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares.

 

As a result of the above, the Company should have classified the Private Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.

 

The Company’s accounting for the Private Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported cash or investments held in the trust account.

 

The table below summarizes the effects of the restatement on the financial statements for all periods being restated. The restatement did not result in a change to net income or cash flows for the three months ended March 31, 2020 and the three and six months ended June 30, 2020 as there was no change in the fair value of the Warrants.

 

   As
Previously
Reported		   Adjustments   As
Restated		 
Balance sheet as of November 7, 2019 (audited)            
Warrant Liability  $—   $3,037,500   $3,037,500 
Common Stock Subject to Possible Redemption   115,562,660    (3,037,500)   112,525,160 
Common Stock   401    31    432 
Additional Paid-in Capital   5,000,221    19,915    5,020,136 
Accumulated Deficit   (621)   (19,946)   (20,567)
                
Balance sheet as of December 31, 2019 (audited)               
Warrant Liability  $—   $1,975,155   $1,975,155 
Common Stock Subject to Possible Redemption   125,680,303    (1,975,155)   123,705,148 
Common Stock   382    20    402 
Additional Paid-in Capital   4,898,117    (1,204,671)   3,693,446 
Retained Earnings   101,502    1,204,651    1,306,153 
                
Balance sheet as of March 31, 2020               
Warrant Liability  $—   $1,975,155   $1,975,155 
Common Stock Subject to Possible Redemption   126,056,624    (1,975,155)   124,081,469 
Common Stock   382    20    402 
Additional Paid-in Capital   4,521,796    (1,204,671)   3,317,125 
Retained Earnings   477,832    1,204,651    1,682,483 
                
Balance sheet as of June 30, 2020               
Warrant Liability  $—   $1,975,155   $1,975,155 
Common Stock Subject to Possible Redemption   125,957,664    (1,975,155)   123,982,509 
Common Stock   383    20    403 
Additional Paid-in Capital   4,620,755    (1,204,671)   3,416,084 
Retained Earnings   378,866    1,204,651    1,583,517 
                
Balance sheet as of September 30, 2020               
Warrant Liability  $—   $2,172,671   $2,172,671 
Common Stock Subject to Possible Redemption   125,871,358    (2,172,671)   123,698,687 
Common Stock   383    22    405 
Additional Paid-in Capital   4,707,061    (1,007,157)   3,699,904 
Retained Earnings   292,558    1,007,135    1,299,693 
                
Balance sheet as of December 31, 2020 (audited)               
Warrant Liability  $—   $3,950,311   $3,950,311 
Common Stock Subject to Possible Redemption   125,781,370    (3,950,311)   121,831,059 
Common Stock   384    40    424 
Additional Paid-in Capital   4,797,048    770,465    5,567,513 
Retained Earnings (Accumulated Deficit)   202,578    (770,505)   (567,927)
                
Statement of Operations for the Period from June 20, 2019 (inception) Through December 31, 2019 (audited)               
Change in fair value of warrant liability  $—   $1,224,597   $1,224,597 
Transaction costs allocable to warrant liability   —    (19,946)   (19,946)
Net income   101,502    1,204,651    1,306,153 
Weighted average shares outstanding, Common Stock subject to possible redemption   12,446,534    (318,172)   12,128,362 
Basic and diluted net income per share, Common Stock subject to possible redemption   0.01    —    0.01 
Weighted average shares outstanding, Common Stock   3,305,465    88,564    3,394,029 
Basic and diluted net loss per share, Common Stock   0.03    0.30    0.33 
                
Statement of Operations for the Three Months Ended March 31, 2020 (unaudited)               
Weighted average shares outstanding, Common Stock subject to possible redemption   12,550,477    (197,240)   12,353,237 
Basic and diluted net income per share, Common Stock subject to possible redemption   0.04    —    0.04 
Weighted average shares outstanding, Common Stock   3,821,463    197,240    4,018,703 
Basic and diluted net loss per share, Common Stock   (0.04)   —    (0.04)

  

     As
Previously
Reported  		    Adjustments    As
Restated		 
Statement of Operations for the Six Months Ended June 30, 2020 (unaudited)               
Weighted average shares outstanding, Common Stock subject to possible redemption   12,553,036    (196,999)   12,356,037 
Basic and diluted net income per share, Common Stock subject to possible redemption   0.04    —    0.04 
Weighted average shares outstanding, Common Stock   3,818,918    196,986    4,015,904 
Basic and diluted net loss per share, Common Stock   (0.07)   0.01    (0.06)
                
Statement of Operations for the Nine Months Ended September 30, 2020 (unaudited)               
Change in fair value of warrant liability  $—   $(197,516)  $197,516 
Net income (loss)   191,056    (197,516)   (6,460)
Weighted average shares outstanding, Common Stock subject to possible redemption   12,550,512    (196,900)   12,353,612 
Basic and diluted net income per share, Common Stock subject to possible redemption   0.05    —    0.05 
Weighted average shares outstanding, Common Stock   3,821,429    196,899    4,018,328 
Basic and diluted net loss per share, Common Stock   (0.10)   (0.04)   (0.14)
                
Statement of Operations for the Year Ended December 31, 2020 (audited)               
Change in fair value of warrant liability  $—   $(1,975,156)  $(1,975,156)
Net income (loss)   101,076    (1,975,156)   (1,874,080)
Weighted average shares outstanding, Common Stock subject to possible redemption   12,547,286    (201,796)   12,345,490 
Basic and diluted net income per share, Common Stock subject to possible redemption   0.05    —    0.05 
Weighted average shares outstanding, Common Stock   3,824,645    201,805    4,026,450 
Basic and diluted net loss per share, Common Stock   (0.12)   (0.48)   (0.60)
                
Cash Flow Statement for the Year Ended December 31, 2019 (audited)               
Net income  $101,502   $1,204,651   $1,306,153 
Change in fair value of warrant liability   —    (1,224,597)   (1,224,597)
Transaction costs associated with Initial Public Offering   —    19,946    19,946 
Initial classification of Common Stock subject to possible redemption   125,578,180    (3,199,752)   122,378,428 
Change in value of Common Stock subject to possible redemption   102,123    1,224,597    1,326,720 
                
Cash Flow Statement for the Nine Months Ended September 30, 2020 (unaudited)               
Net income (loss)  $191,056   $(197,516)  $(6,460)
Change in fair value of warrant liability   —    197,516    197,516 
Change in value of Common Stock subject to possible redemption   191,055    (197,516)   (6,461)
                
Cash Flow Statement for the Year Ended December 31, 2020 (audited)               
Net income (loss)  $101,076   $(1,975,156)  $(1,874,080)
Change in fair value of warrant liability   —    1,975,156    1,975,156 
Change in value of Common Stock subject to possible redemption   101,067    (1,975,156)   (1,874,089)